Copyright Reports & Markets. All rights reserved.

Global Weizmannia Coagulans Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Weizmannia Coagulans Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Less than 20 Billion CFU/g
    • 1.3.3 20-100 Billion CFU/g
    • 1.3.4 Great than 100 Billion CFU/g
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Weizmannia Coagulans Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Food
    • 1.4.3 Health Products
    • 1.4.4 Personal Care
    • 1.4.5 Pet Nutrition
    • 1.4.6 Other
  • 1.5 Global Weizmannia Coagulans Market Size & Forecast
    • 1.5.1 Global Weizmannia Coagulans Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Weizmannia Coagulans Sales Quantity (2020-2031)
    • 1.5.3 Global Weizmannia Coagulans Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Sabinsa
    • 2.1.1 Sabinsa Details
    • 2.1.2 Sabinsa Major Business
    • 2.1.3 Sabinsa Weizmannia Coagulans Product and Services
    • 2.1.4 Sabinsa Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Sabinsa Recent Developments/Updates
  • 2.2 Mitsubishi Chemical Group Corporation.
    • 2.2.1 Mitsubishi Chemical Group Corporation. Details
    • 2.2.2 Mitsubishi Chemical Group Corporation. Major Business
    • 2.2.3 Mitsubishi Chemical Group Corporation. Weizmannia Coagulans Product and Services
    • 2.2.4 Mitsubishi Chemical Group Corporation. Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Mitsubishi Chemical Group Corporation. Recent Developments/Updates
  • 2.3 Helplifes
    • 2.3.1 Helplifes Details
    • 2.3.2 Helplifes Major Business
    • 2.3.3 Helplifes Weizmannia Coagulans Product and Services
    • 2.3.4 Helplifes Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Helplifes Recent Developments/Updates
  • 2.4 ILDONG Bioscience
    • 2.4.1 ILDONG Bioscience Details
    • 2.4.2 ILDONG Bioscience Major Business
    • 2.4.3 ILDONG Bioscience Weizmannia Coagulans Product and Services
    • 2.4.4 ILDONG Bioscience Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 ILDONG Bioscience Recent Developments/Updates
  • 2.5 JuneYao Health (BioGrowing Co., Ltd)
    • 2.5.1 JuneYao Health (BioGrowing Co., Ltd) Details
    • 2.5.2 JuneYao Health (BioGrowing Co., Ltd) Major Business
    • 2.5.3 JuneYao Health (BioGrowing Co., Ltd) Weizmannia Coagulans Product and Services
    • 2.5.4 JuneYao Health (BioGrowing Co., Ltd) Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 JuneYao Health (BioGrowing Co., Ltd) Recent Developments/Updates
  • 2.6 Chr. Hansen
    • 2.6.1 Chr. Hansen Details
    • 2.6.2 Chr. Hansen Major Business
    • 2.6.3 Chr. Hansen Weizmannia Coagulans Product and Services
    • 2.6.4 Chr. Hansen Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Chr. Hansen Recent Developments/Updates
  • 2.7 Unique Biotech Ltd.
    • 2.7.1 Unique Biotech Ltd. Details
    • 2.7.2 Unique Biotech Ltd. Major Business
    • 2.7.3 Unique Biotech Ltd. Weizmannia Coagulans Product and Services
    • 2.7.4 Unique Biotech Ltd. Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Unique Biotech Ltd. Recent Developments/Updates
  • 2.8 Microbiologics
    • 2.8.1 Microbiologics Details
    • 2.8.2 Microbiologics Major Business
    • 2.8.3 Microbiologics Weizmannia Coagulans Product and Services
    • 2.8.4 Microbiologics Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Microbiologics Recent Developments/Updates
  • 2.9 SYNBIO TECH INC.
    • 2.9.1 SYNBIO TECH INC. Details
    • 2.9.2 SYNBIO TECH INC. Major Business
    • 2.9.3 SYNBIO TECH INC. Weizmannia Coagulans Product and Services
    • 2.9.4 SYNBIO TECH INC. Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 SYNBIO TECH INC. Recent Developments/Updates
  • 2.10 WECARE Probiotics
    • 2.10.1 WECARE Probiotics Details
    • 2.10.2 WECARE Probiotics Major Business
    • 2.10.3 WECARE Probiotics Weizmannia Coagulans Product and Services
    • 2.10.4 WECARE Probiotics Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 WECARE Probiotics Recent Developments/Updates
  • 2.11 Advenza
    • 2.11.1 Advenza Details
    • 2.11.2 Advenza Major Business
    • 2.11.3 Advenza Weizmannia Coagulans Product and Services
    • 2.11.4 Advenza Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Advenza Recent Developments/Updates
  • 2.12 Artechno
    • 2.12.1 Artechno Details
    • 2.12.2 Artechno Major Business
    • 2.12.3 Artechno Weizmannia Coagulans Product and Services
    • 2.12.4 Artechno Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Artechno Recent Developments/Updates
  • 2.13 Wuxi Accobio Biotech Inc
    • 2.13.1 Wuxi Accobio Biotech Inc Details
    • 2.13.2 Wuxi Accobio Biotech Inc Major Business
    • 2.13.3 Wuxi Accobio Biotech Inc Weizmannia Coagulans Product and Services
    • 2.13.4 Wuxi Accobio Biotech Inc Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Wuxi Accobio Biotech Inc Recent Developments/Updates
  • 2.14 Sanzyme Biologics
    • 2.14.1 Sanzyme Biologics Details
    • 2.14.2 Sanzyme Biologics Major Business
    • 2.14.3 Sanzyme Biologics Weizmannia Coagulans Product and Services
    • 2.14.4 Sanzyme Biologics Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Sanzyme Biologics Recent Developments/Updates
  • 2.15 Shandong Zhongke-Jiayi Bioengineering Co., Ltd
    • 2.15.1 Shandong Zhongke-Jiayi Bioengineering Co., Ltd Details
    • 2.15.2 Shandong Zhongke-Jiayi Bioengineering Co., Ltd Major Business
    • 2.15.3 Shandong Zhongke-Jiayi Bioengineering Co., Ltd Weizmannia Coagulans Product and Services
    • 2.15.4 Shandong Zhongke-Jiayi Bioengineering Co., Ltd Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Shandong Zhongke-Jiayi Bioengineering Co., Ltd Recent Developments/Updates
  • 2.16 Kerry Group
    • 2.16.1 Kerry Group Details
    • 2.16.2 Kerry Group Major Business
    • 2.16.3 Kerry Group Weizmannia Coagulans Product and Services
    • 2.16.4 Kerry Group Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Kerry Group Recent Developments/Updates
  • 2.17 Cambridge Commodities
    • 2.17.1 Cambridge Commodities Details
    • 2.17.2 Cambridge Commodities Major Business
    • 2.17.3 Cambridge Commodities Weizmannia Coagulans Product and Services
    • 2.17.4 Cambridge Commodities Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Cambridge Commodities Recent Developments/Updates
  • 2.18 Specialty Enzymes & Probiotics
    • 2.18.1 Specialty Enzymes & Probiotics Details
    • 2.18.2 Specialty Enzymes & Probiotics Major Business
    • 2.18.3 Specialty Enzymes & Probiotics Weizmannia Coagulans Product and Services
    • 2.18.4 Specialty Enzymes & Probiotics Weizmannia Coagulans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Specialty Enzymes & Probiotics Recent Developments/Updates

3 Competitive Environment: Weizmannia Coagulans by Manufacturer

  • 3.1 Global Weizmannia Coagulans Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Weizmannia Coagulans Revenue by Manufacturer (2020-2025)
  • 3.3 Global Weizmannia Coagulans Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Weizmannia Coagulans by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Weizmannia Coagulans Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Weizmannia Coagulans Manufacturer Market Share in 2024
  • 3.5 Weizmannia Coagulans Market: Overall Company Footprint Analysis
    • 3.5.1 Weizmannia Coagulans Market: Region Footprint
    • 3.5.2 Weizmannia Coagulans Market: Company Product Type Footprint
    • 3.5.3 Weizmannia Coagulans Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Weizmannia Coagulans Market Size by Region
    • 4.1.1 Global Weizmannia Coagulans Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Weizmannia Coagulans Consumption Value by Region (2020-2031)
    • 4.1.3 Global Weizmannia Coagulans Average Price by Region (2020-2031)
  • 4.2 North America Weizmannia Coagulans Consumption Value (2020-2031)
  • 4.3 Europe Weizmannia Coagulans Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Weizmannia Coagulans Consumption Value (2020-2031)
  • 4.5 South America Weizmannia Coagulans Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Weizmannia Coagulans Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Weizmannia Coagulans Sales Quantity by Type (2020-2031)
  • 5.2 Global Weizmannia Coagulans Consumption Value by Type (2020-2031)
  • 5.3 Global Weizmannia Coagulans Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Weizmannia Coagulans Sales Quantity by Application (2020-2031)
  • 6.2 Global Weizmannia Coagulans Consumption Value by Application (2020-2031)
  • 6.3 Global Weizmannia Coagulans Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Weizmannia Coagulans Sales Quantity by Type (2020-2031)
  • 7.2 North America Weizmannia Coagulans Sales Quantity by Application (2020-2031)
  • 7.3 North America Weizmannia Coagulans Market Size by Country
    • 7.3.1 North America Weizmannia Coagulans Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Weizmannia Coagulans Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Weizmannia Coagulans Sales Quantity by Type (2020-2031)
  • 8.2 Europe Weizmannia Coagulans Sales Quantity by Application (2020-2031)
  • 8.3 Europe Weizmannia Coagulans Market Size by Country
    • 8.3.1 Europe Weizmannia Coagulans Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Weizmannia Coagulans Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Weizmannia Coagulans Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Weizmannia Coagulans Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Weizmannia Coagulans Market Size by Region
    • 9.3.1 Asia-Pacific Weizmannia Coagulans Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Weizmannia Coagulans Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Weizmannia Coagulans Sales Quantity by Type (2020-2031)
  • 10.2 South America Weizmannia Coagulans Sales Quantity by Application (2020-2031)
  • 10.3 South America Weizmannia Coagulans Market Size by Country
    • 10.3.1 South America Weizmannia Coagulans Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Weizmannia Coagulans Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Weizmannia Coagulans Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Weizmannia Coagulans Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Weizmannia Coagulans Market Size by Country
    • 11.3.1 Middle East & Africa Weizmannia Coagulans Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Weizmannia Coagulans Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Weizmannia Coagulans Market Drivers
  • 12.2 Weizmannia Coagulans Market Restraints
  • 12.3 Weizmannia Coagulans Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Weizmannia Coagulans and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Weizmannia Coagulans
  • 13.3 Weizmannia Coagulans Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Weizmannia Coagulans Typical Distributors
  • 14.3 Weizmannia Coagulans Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Weizmannia Coagulans market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Weizmannia coagulans, formerly known as Bacillus coagulans, is a Gram-positive, rod-shaped bacterium that has gained attention for its potential health benefits. This resilient microorganism can withstand extreme conditions, making it an ideal probiotic candidate.Weizmannia coagulans is a Gram-positive bacterium that can produce both lactic acid and spores. It was first isolated by Hammer in 1915. Weizmannia coagulans is a probiotic that has been jointly certified for safe use by the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA).
    This report is a detailed and comprehensive analysis for global Weizmannia Coagulans market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Weizmannia Coagulans market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
    Global Weizmannia Coagulans market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
    Global Weizmannia Coagulans market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
    Global Weizmannia Coagulans market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Weizmannia Coagulans
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Weizmannia Coagulans market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sabinsa, Mitsubishi Chemical Group Corporation., Helplifes, ILDONG Bioscience, JuneYao Health (BioGrowing Co., Ltd), Chr. Hansen, Unique Biotech Ltd., Microbiologics, SYNBIO TECH INC., WECARE Probiotics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Weizmannia Coagulans market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Less than 20 Billion CFU/g
    20-100 Billion CFU/g
    Great than 100 Billion CFU/g
    Market segment by Application
    Food
    Health Products
    Personal Care
    Pet Nutrition
    Other
    Major players covered
    Sabinsa
    Mitsubishi Chemical Group Corporation.
    Helplifes
    ILDONG Bioscience
    JuneYao Health (BioGrowing Co., Ltd)
    Chr. Hansen
    Unique Biotech Ltd.
    Microbiologics
    SYNBIO TECH INC.
    WECARE Probiotics
    Advenza
    Artechno
    Wuxi Accobio Biotech Inc
    Sanzyme Biologics
    Shandong Zhongke-Jiayi Bioengineering Co., Ltd
    Kerry Group
    Cambridge Commodities
    Specialty Enzymes & Probiotics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Weizmannia Coagulans product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Weizmannia Coagulans, with price, sales quantity, revenue, and global market share of Weizmannia Coagulans from 2020 to 2025.
    Chapter 3, the Weizmannia Coagulans competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Weizmannia Coagulans breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Weizmannia Coagulans market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Weizmannia Coagulans.
    Chapter 14 and 15, to describe Weizmannia Coagulans sales channel, distributors, customers, research findings and conclusion.

    Buy now